The global Ketoprofen market size was valued at US$ 37.4 million in 2024 and is forecast to a readjusted size of USD 42.5 million by 2031 with a CAGR of 1.9% during review period.
Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.
In this research the statistics are Ketoprofen BPC (bulk pharmaceutical chemicals).
China is the largest Ketoprofen market with about 68% market share. Europe is follower, accounting for about 18% market share.
The key players are SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, Hubei Xunda etc. Top 3 companies occupied about 83% market share.
This report is a detailed and comprehensive analysis for global Ketoprofen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ketoprofen market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2020-2031
Global Ketoprofen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2020-2031
Global Ketoprofen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2020-2031
Global Ketoprofen market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ketoprofen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ketoprofen market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, Hubei Xunda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Ketoprofen market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Ketoprofen above 99.5%
Ketoprofen below 99.5%
麻豆原创 segment by Application
Ketoprofen Tablets
Ketoprofen Capsules
Ketoprofen Gel
Others
Major players covered
SANOFI-Aventis
Boehringer-Ingelheim
BEC
Zhejiang Jiuzhou
Hubei Xunda
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ketoprofen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ketoprofen, with price, sales quantity, revenue, and global market share of Ketoprofen from 2020 to 2025.
Chapter 3, the Ketoprofen competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ketoprofen breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ketoprofen market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ketoprofen.
Chapter 14 and 15, to describe Ketoprofen sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Ketoprofen Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Ketoprofen above 99.5%
1.3.3 Ketoprofen below 99.5%
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Ketoprofen Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Ketoprofen Tablets
1.4.3 Ketoprofen Capsules
1.4.4 Ketoprofen Gel
1.4.5 Others
1.5 Global Ketoprofen 麻豆原创 Size & Forecast
1.5.1 Global Ketoprofen Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Ketoprofen Sales Quantity (2020-2031)
1.5.3 Global Ketoprofen Average Price (2020-2031)
2 Manufacturers Profiles
2.1 SANOFI-Aventis
2.1.1 SANOFI-Aventis Details
2.1.2 SANOFI-Aventis Major Business
2.1.3 SANOFI-Aventis Ketoprofen Product and Services
2.1.4 SANOFI-Aventis Ketoprofen Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 SANOFI-Aventis Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Ketoprofen Product and Services
2.2.4 Boehringer-Ingelheim Ketoprofen Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 BEC
2.3.1 BEC Details
2.3.2 BEC Major Business
2.3.3 BEC Ketoprofen Product and Services
2.3.4 BEC Ketoprofen Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 BEC Recent Developments/Updates
2.4 Zhejiang Jiuzhou
2.4.1 Zhejiang Jiuzhou Details
2.4.2 Zhejiang Jiuzhou Major Business
2.4.3 Zhejiang Jiuzhou Ketoprofen Product and Services
2.4.4 Zhejiang Jiuzhou Ketoprofen Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Zhejiang Jiuzhou Recent Developments/Updates
2.5 Hubei Xunda
2.5.1 Hubei Xunda Details
2.5.2 Hubei Xunda Major Business
2.5.3 Hubei Xunda Ketoprofen Product and Services
2.5.4 Hubei Xunda Ketoprofen Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Hubei Xunda Recent Developments/Updates
3 Competitive Environment: Ketoprofen by Manufacturer
3.1 Global Ketoprofen Sales Quantity by Manufacturer (2020-2025)
3.2 Global Ketoprofen Revenue by Manufacturer (2020-2025)
3.3 Global Ketoprofen Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Ketoprofen by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Ketoprofen Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Ketoprofen Manufacturer 麻豆原创 Share in 2024
3.5 Ketoprofen 麻豆原创: Overall Company Footprint Analysis
3.5.1 Ketoprofen 麻豆原创: Region Footprint
3.5.2 Ketoprofen 麻豆原创: Company Product Type Footprint
3.5.3 Ketoprofen 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Ketoprofen 麻豆原创 Size by Region
4.1.1 Global Ketoprofen Sales Quantity by Region (2020-2031)
4.1.2 Global Ketoprofen Consumption Value by Region (2020-2031)
4.1.3 Global Ketoprofen Average Price by Region (2020-2031)
4.2 North America Ketoprofen Consumption Value (2020-2031)
4.3 Europe Ketoprofen Consumption Value (2020-2031)
4.4 Asia-Pacific Ketoprofen Consumption Value (2020-2031)
4.5 South America Ketoprofen Consumption Value (2020-2031)
4.6 Middle East & Africa Ketoprofen Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Ketoprofen Sales Quantity by Type (2020-2031)
5.2 Global Ketoprofen Consumption Value by Type (2020-2031)
5.3 Global Ketoprofen Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Ketoprofen Sales Quantity by Application (2020-2031)
6.2 Global Ketoprofen Consumption Value by Application (2020-2031)
6.3 Global Ketoprofen Average Price by Application (2020-2031)
7 North America
7.1 North America Ketoprofen Sales Quantity by Type (2020-2031)
7.2 North America Ketoprofen Sales Quantity by Application (2020-2031)
7.3 North America Ketoprofen 麻豆原创 Size by Country
7.3.1 North America Ketoprofen Sales Quantity by Country (2020-2031)
7.3.2 North America Ketoprofen Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Ketoprofen Sales Quantity by Type (2020-2031)
8.2 Europe Ketoprofen Sales Quantity by Application (2020-2031)
8.3 Europe Ketoprofen 麻豆原创 Size by Country
8.3.1 Europe Ketoprofen Sales Quantity by Country (2020-2031)
8.3.2 Europe Ketoprofen Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Ketoprofen Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Ketoprofen Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Ketoprofen 麻豆原创 Size by Region
9.3.1 Asia-Pacific Ketoprofen Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Ketoprofen Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Ketoprofen Sales Quantity by Type (2020-2031)
10.2 South America Ketoprofen Sales Quantity by Application (2020-2031)
10.3 South America Ketoprofen 麻豆原创 Size by Country
10.3.1 South America Ketoprofen Sales Quantity by Country (2020-2031)
10.3.2 South America Ketoprofen Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Ketoprofen Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Ketoprofen Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Ketoprofen 麻豆原创 Size by Country
11.3.1 Middle East & Africa Ketoprofen Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Ketoprofen Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Ketoprofen 麻豆原创 Drivers
12.2 Ketoprofen 麻豆原创 Restraints
12.3 Ketoprofen Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Ketoprofen and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ketoprofen
13.3 Ketoprofen Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ketoprofen Typical Distributors
14.3 Ketoprofen Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
SANOFI-Aventis
Boehringer-Ingelheim
BEC
Zhejiang Jiuzhou
Hubei Xunda
听
听
*If Applicable.
